Viral Hepatitis clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • Tobevibart + Elebsiran in Chronic HDV Infection

    Sorry, in progress, not accepting new patients

    This is a multicenter, open label, randomized Phase 3 clinical study to evaluate the efficacy and safety of the combination of tobevibart + elebsiran for the treatment of chronic hepatitis delta in comparison to delayed treatment.

    San Francisco, California and other locations

Our lead scientists for Viral Hepatitis research studies include .

Last updated: